11 Tree Pollen Mix
NDC 22840-9484, Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana, solution, from Greer Laboratories, Inc..
- Product NDC
- 22840-9484
- Status
- Listed
- Labeler
- Greer Laboratories, Inc.
- Dosage form
- SOLUTION
- Route
- INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
- Product type
- NON-STANDARDIZED ALLERGENIC
- Marketing category
- BLA
- Application
- BLA101833
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/22840-9484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARYA OVATA POLLEN.0045454 g/mL
- ULMUS AMERICANA POLLEN.0045454 g/mL
- PLATANUS OCCIDENTALIS POLLEN.0045454 g/mL
- JUGLANS NIGRA POLLEN.0045454 g/mL
- SALIX NIGRA POLLEN.0045454 g/mL
- FAGUS GRANDIFOLIA POLLEN.0045454 g/mL
- BETULA NIGRA POLLEN.0045454 g/mL
- ACER SACCHARUM POLLEN.0045454 g/mL
- POPULUS DELTOIDES POLLEN.0045454 g/mL
- FRAXINUS AMERICANA POLLEN.0045454 g/mL
- QUERCUS RUBRA POLLEN.0045454 g/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 22840-9484-2 | 22840948402 | 10 mL in 1 VIAL, MULTI-DOSE (22840-9484-2) |
| 22840-9484-4 | 22840948404 | 50 mL in 1 VIAL, MULTI-DOSE (22840-9484-4) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 22840-9484 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/22840-9484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 22840-9484. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.